BIO-TECHNE TO SHOWCASE INNOVATIVE CANCER RESEARCH, CELL THERAPY AND MANUFACTURING TOOLS AT AACR 2023 CONFERENCEPRNewsWire • 04/13/23
BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 3, 2023, TO ANNOUNCE THIRD QUARTER 2023 FINANCIAL RESULTSPRNewsWire • 04/12/23
BIO-TECHNE CELEBRATES MILESTONE WITH MORE THAN 1,000 ELLA™ INSTRUMENTS NOW IN OPERATIONPRNewsWire • 04/05/23
Increase': "Immunoassay Market Soars to New Heights, Predicted to Surpass USD 51.95 Billion by 2030 with a Strong CAGRGlobeNewsWire • 03/29/23
BIO-TECHNE ANNOUNCES COMPLETION OF CELL AND GENE THERAPY CATAPULT PROCESS ANALYTICAL TECHNOLOGY (PAT) CONSORTIUMPRNewsWire • 03/15/23
BIO-TECHNE TO PRESENT AT THE CITI 2023 HEALTHCARE SERVICES, MEDTECH, TOOLS & HCIT CONFERENCEPRNewsWire • 02/22/23
BIO-TECHNE AND CELL SIGNALING TECHNOLOGY ANNOUNCE PARTNERSHIP TO VALIDATE SIMPLE WESTERN ANTIBODIESPRNewsWire • 02/14/23
Techne (TECH) Earnings Expected to Grow: What to Know Ahead of Next Week's ReleaseZacks Investment Research • 01/26/23
BIO-TECHNE LAUNCHES THE MauriceFlex™ SYSTEM, ADDING cIEF FRACTIONATION CAPABILITY TO THE GOLD STANDARD MAURICE ASSAYSPRNewsWire • 01/26/23